← Silence Therapeutics plc

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations — — — — — ($45.3m) ($88.6m)
Net Income (Loss) Attributable to Parent — — — — — ($45.3m) ($88.6m)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest ($19.6m) ($32.5m) ($39.4m) ($40.5m) ($43.3m) ($45.3m) ($88.6m)
Depreciation — — — — — $336k $312k
Amortization — — — — — $257k $243k
Depreciation charges $452k $476k $411k $478k $462k — —
Amortization charges $30k $20k $16k $4k $36k — —
Amortization Cash Flow — — — — — $257k $243k
Amortization Of Intangibles — — — — — $257k $243k
Depreciation Amortization Depletion — — — — — $593k $555k
Deferred Income Tax Expense (Benefit) — — — — — $845k $11k
Deferred Income Tax — — — — — $845k $11k
Deferred Tax — — — — — $845k $11k
Share-based Payment Arrangement, Noncash Expense — — — — — $16.3m $8.1m
Adjustments For Share-Based Payments $584k $4.4m $8.6m $10.3m $13.1m — —
Share-based Payment Arrangement, Expense — — — — — $16.3m $8.1m
Goodwill, Impairment Loss — — — — — $0 $0
Impairment of Intangible Assets (Excluding Goodwill) — — — — — $0 $0
Charge for the year in respect of share-based payments $584k $4.4m $8.6m $10.3m $13.1m — —
Income Tax Expense (Benefit) — — — — — $845k $11k
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable — — — — — $904k ($1.0m)
Adjustments For Current Tax Of Prior Period ($228k) $42k ($875k) $401k ($15k) — —
Adjustments For Finance Costs $163k $323k $52k — $2.2m — —
Adjustments For Finance Income $27k $129k $10k $1.3m $1.4m — —
Foreign Currency Transaction Gain (Loss), before Tax — — — — — $646k ($8.5m)
General and Administrative Expense — — $20.0m $19.6m $20.6m $26.9m $22.3m
Goodwill $7.7m $8.1m $7.6m $8.0m $7.8m $9.4m $10.6m
Payments Of Lease Liabilities Classified As Financing Activities — $402k $211k $190k $174k — —
Proceeds From Issuing Shares $5.3m $15.8m $30.9m $43.2m $25.3m — —
Purchase Of Intangible Assets Classified As Investing Activities — $3k $23k $300k — — —
Loss before tax ($22.9m) ($36.0m) ($45.9m) ($47.4m) ($50.3m) — —
Net foreign exchange (gain)/loss — $4.9m $305k $713k $2.2m — —
Finance and other expenses $163k $323k $52k — $2.2m — —
Finance and other income ($27k) ($129k) ($10k) ($1.3m) ($1.4m) — —
(Increase)/decrease in trade and other receivables ($4k) ($29.3m) $27.5m ($584k) $314k — —
Increase in other current assets ($4k) ($3.7m) ($904k) ($4.2m) $610k — —
(Increase) in R&D tax credit receivable — — — ($502k) ($1.8m) — —
Increase in trade and other payables $3.1m $1.3m $2.4m $1.4m $44k — —
(Decrease)/increase in contract liabilities $18.0m $50.4m $8.4m ($4.4m) ($8.3m) — —
Cash generated/(spent) on operations ($581k) ($13.8m) $2.4m ($45.5m) ($45.6m) — —
R&D tax credits received $2.3m $3.0m $4.4m $7.8m $6.9m — —
Redemption of financial assets at amortized cost - term deposits ($15.0m) $10.0m $10.0m — $36.2m — —
Purchase of financial assets at amortized cost — — — ($16.1m) ($20.7m) — —
Interest received ($6k) $129k $10k $23k $958k — —
Purchase of intangible assets — ($3k) ($23k) ($300k) — — —
Repayment of lease liabilities — ($402k) ($211k) ($190k) ($174k) — —
Proceeds from issue of share capital $5.3m $15.8m $30.9m $43.2m $25.3m — —
Beginning Cash Position — — — — — $68.8m $121.3m
Cash Flow From Continuing Financing Activities — — — — — $142.1m $15k
Cash Flow From Continuing Investing Activities — — — — — ($22.0m) ($48.0m)
Change In Other Current Assets — — — — — ($1.3m) $9.7m
Change In Other Current Liabilities — — — — — ($165k) ($168k)
Change In Other Working Capital — — — — — ($28.8m) ($334k)
Change In Payable — — — — — $499k ($4.1m)
Change In Payables And Accrued Expense — — — — — $499k ($4.1m)
Change In Receivables — — — — — ($3.2m) $5.1m
Change In Working Capital — — — — — ($33.0m) $10.2m
Changes In Account Receivables — — — — — ($904k) $1.0m
Changes In Cash — — — — — $52.5m ($110.2m)
End Cash Position — — — — — $121.3m $11.3m
Financing Cash Flow — — — — — $142.1m $15k
Free Cash Flow — — — — — ($67.9m) ($62.3m)
Gain Loss On Sale Of PPE — — $0 $0 — — —
Interest Received CFI — — $13k $28k $1.2m — —
Investing Cash Flow — — — — — ($22.0m) ($48.0m)
Issuance Of Capital Stock — — — — — $142.1m $15k
Net Foreign Currency Exchange Gain Loss — — — — — ($2.6m) $11.0m
Net Intangibles Purchase And Sale — — ($31k) — $0 $0 —
Net PPE Purchase And Sale — — — — — ($211k) ($55k)
Operating Gains Losses — — — — — ($2.6m) $11.0m
Other Non Cash Items — — — — — ($4.5m) ($3.5m)
Purchase Of Intangibles — — ($31k) — $0 $0 —
Purchase Of PPE — — — — — ($211k) ($55k)
Sale Of PPE — — $0 $0 — — —
Stock Based Compensation — — — — — $16.3m $8.1m
Net Cash Provided by (Used in) Operating Activities $1.7m ($10.8m) $6.8m ($45.5m) ($39.4m) ($67.6m) ($62.3m)
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment ($9k) ($511k) ($1.3m) ($140k) ($45k) $211k $55k
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities — $3k — — — — —
Net Investment Purchase And Sale — — — — — ($21.8m) ($47.9m)
Purchase Of Investment — — — — — ($139.2m) ($166.4m)
Sale Of Investment — — — $0 — $117.4m $118.5m
Net cash (outflow)/inflow from investing activities ($15.0m) $9.6m $8.7m ($16.5m) $16.4m — —
Net Cash Provided by (Used in) Investing Activities — — — — — ($22.0m) ($48.0m)
Cash flows from financing activities:
Net Issuance Payments Of Debt — — ($285k) ($230k) ($222k) — —
Net Long Term Debt Issuance — — ($285k) ($230k) ($222k) — —
Long Term Debt Payments — — ($285k) ($230k) ($222k) — —
Repayment Of Debt — — ($285k) ($230k) ($222k) — —
Proceeds from Issuance of Common Stock — — — — — $142.1m $15k
Common Stock Issuance — — — — — $142.1m $15k
Net Common Stock Issuance — — — — — $142.1m $15k
Net cash inflow from financing activities $5.3m $15.4m $30.7m $43.0m $25.2m — —
Net Cash Provided by (Used in) Financing Activities — — — — — $142.1m $15k
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — — — — $60k $195k
Effect of exchange rate fluctuations on cash and cash equivalents held $36k ($336k) ($105k) $228k ($3.0m) — —
Effect Of Exchange Rate Changes — — — — — $60k $195k
(Decrease)/increase in cash and cash equivalents ($8.0m) $14.3m $46.2m ($18.9m) $2.2m — —
Cash, Cash Equivalents, and Short-term Investments — — — — — $147.3m $85.1m
Cash and cash equivalents at start of year $13.5m $27.4m $73.5m $54.8m $54.0m — —
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported — — — — — $52.5m ($110.2m)
Income Taxes Paid, Net — — — — ($642k) ($433k) $637k

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.